In a previous study, Periostin has been shown to participate in osteoblast differentiation through Wnt/β-Catenin signaling (Bonnet et al., 2012; Zhang et al., 2017), which suggests that Periostin may be a novel target for osteoporosis therapy. Here, POSTN is linked to osteoporosis.